Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Notchless protein homolog 1 (NLE1) is a WD-repeat-containing protein that acts as a regulatory factor in the Notch signaling pathway and is implicated in controlling the expression of cell cycle and proliferation genes, such as CDKN1A and members of the Wnt pathway. It is normally localized to the nucleolus and nucleoplasm and is required for embryonic development and stem cell survival. NLE1 is overexpressed in several human cancers, where it acts as a tumor promoter by accelerating cell proliferation and suppressing apoptosis, frequently through activation of E2F1-mediated transcription of cell cycle regulators like CDK1 and activation of the PI3K/Akt pathway. NLE1 also serves as a diagnostic and prognostic biomarker for hepatocellular carcinoma and is under investigation as a novel therapeutic target, with some evidence supporting sensitivity to specific small molecule inhibitors.
Small molecule inhibition of NLE1 function (shown to affect HCC proliferation), indirect modulation of cell cycle regulators (E2F1-mediated CDK1 pathway)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Notchless protein homolog 1 (NLE1).